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Abstract
Background: Acute urinary tract infections (UTI) are one of the most common bacterial infections among women
presenting to primary care. However, there is a lack of consensus regarding the optimal reference standard
threshold for diagnosing UTI. The objective of this systematic review is to determine the diagnostic accuracy of
symptoms and signs in women presenting with suspected UTI, across three different reference standards (102 or
103 or 105 CFU/ml). We also examine the diagnostic value of individual symptoms and signs combined with
dipstick test results in terms of clinical decision making.
Methods: Searches were performed through PubMed (1966 to April 2010), EMBASE (1973 to April 2010), Cochrane
library (1973 to April 2010), Google scholar and reference checking.
Studies that assessed the diagnostic accuracy of symptoms and signs of an uncomplicated UTI using a urine cul-
ture from a clean-catch or catherised urine specimen as the reference standard, with a reference standard of at
least ≥ 102 CFU/ml were included. Synthesised data from a high quality systematic review were used regarding
dipstick results. Studies were combined using a bivariate random effects model.
Results: Sixteen studies incorporating 3,711 patients are included. The weighted prior probability of UTI varies across
diagnostic threshold, 65.1% at ≥ 102 CFU/ml; 55.4% at ≥ 103 CFU/ml and 44.8% at ≥ 102 CFU/ml ≥ 105 CFU/ml. Six
symptoms are identified as useful diagnostic symptoms when a threshold of ≥ 102 CFU/ml is the reference standard.
Presence of dysuria (+LR 1.30 95% CI 1.20-1.41), frequency (+LR 1.10 95% CI 1.04-1.16), hematuria (+LR 1.72 95%CI
1.30-2.27), nocturia (+LR 1.30 95% CI 1.08-1.56) and urgency (+LR 1.22 95% CI 1.11-1.34) all increase the probability of
UTI. The presence of vaginal discharge (+LR 0.65 95% CI 0.51-0.83) decreases the probability of UTI. Presence of
hematuria has the highest diagnostic utility, raising the post-test probability of UTI to 75.8% at ≥ 102 CFU/ml and
67.4% at ≥ 103 CFU/ml. Probability of UTI increases to 93.3% and 90.1% at ≥ 102 CFU/ml and ≥ 103 CFU/ml
respectively when presence of hematuria is combined with a positive dipstick result for nitrites. Subgroup analysis
shows improved diagnostic accuracy using lower reference standards ≥ 102 CFU/ml and ≥ 103 CFU/ml.
Conclusions: Individual symptoms and signs have a modest ability to raise the pretest-risk of UTI. Diagnostic
accuracy improves considerably when combined with dipstick tests particularly tests for nitrites.
Background
Acute uncomplicated urinary tract infections (UTI) are
one of the most common bacterial infections among
women presenting to primary care, with an annual inci-
dence of 7% for all ages of women peaking at 15-24 years
and women older than 65 [1]. Approximately one third
of all women have had at least one physician-diagnosed
uncomplicated UTI by the age of 26 years [2].
The original reference standard for diagnosing UTI was
the presence of significant bacteriuria, defined as the iso-
lation of at least 105 colony-forming units (CFU) of a sin-
gle uropathogen, in a clean catch or catherised urine
specimen [3]. However, this cut-off limit has been
debated in recent years resulting in the use of reduced
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diagnostic thresholds ranging from 102 [4-7] and 103
[8-11].
The pre-test probability of asymptomatic bacteriuria in
women of reproductive age is approximately 5% [12,13].
However, the pre-test probability of an uncomplicated
UTI is shown to increase from 5% to 50% among women
presenting with at least one symptom of an uncompli-
cated UTI [14]. Symptoms of an uncomplicated UTI
include dysuria (painful voiding), frequency (frequent
voiding of urine), urgency (the urge to void immediately),
and hematuria (presence of blood in urine). In contrast,
patients presenting with vaginal discharge or irritation
have a decreased risk of an uncomplicated UTI [14]. The
presence or absence of symptoms function as useful diag-
nostic tests. Near patient testing in the form of urinary
dipsticks are also commonly used in Primary Care to
improve the precision of UTI diagnosis, providing
immediate results which can be interpreted alongside
patient symptoms.
Although empirical treatment of UTI is most cost-
effective [15,16], prescribing without confirmation of
diagnosis contributes to the growing problem of resis-
tance against uropathogens in primary care [17].
A previous systematic review established the diagnostic
accuracy of symptoms and signs for UTI [14], however, it
remains unclear whether the diagnostic accuracy of
symptoms and signs varies when alternative reference
standards are applied. The aim of this systematic review
is to determine the diagnostic accuracy of symptoms and
signs of UTI in adult women across three different refer-
ence standards, 102, 103 and 105 CFU/ml. In addition, we
aim to determine the diagnostic accuracy of symptoms
and signs combined with dipstick test results.
Methods
The PRISMA guidelines for reporting on systematic
reviews and meta-analysis were followed to conduct this
review (Additional file 1).
Search strategy
We performed a systematic search of three online data-
bases, Pubmed (1966 to April 2010), Embase (1973 to
April 2010) and the Cochrane Library (1973 to April
2010). A combination of MeSH terms and text words
were used including: ‘urinary tract infection/pyelone-
phritis/cystitis/urethritis’, ‘physical examination/medical
history taking/professional competence’, ‘sensitivity and
specificity’, ‘ reproducibility of results/diagnostic tests,
routine/decision support techniques/bayes theorem/pre-
dictive value of tests’. All combinations were restricted
to ‘women and female’. This search was supplemented
by checking references of filtered papers and searching
Google Scholar [18]. No restrictions were placed on
language.
Study selection
To be eligible for inclusion, the studies had to fulfil the
following criteria:
1) Have a study population of adult symptomatic
women with suspected uncomplicated UTI present-
ing to a primary care setting.
2) Use a cohort or cross-sectional study design. Case
control studies were excluded.
3) Investigate the diagnostic accuracy of symptoms
and signs of UTI using a urine culture from a clean-
catch or catherised urine specimen as the reference
test, with a diagnostic threshold of at least ≥ 102
CFU/ml.
4) Include sufficient data to allow for the calculation
of sensitivity, specificity, negative and positive pre-
dictive values and the prevalence of uncomplicated
UTI.
Data extraction
The number of true positives, false positives, true nega-
tives and false negatives for each sign and symptom
were extracted from each of the studies and a 2 × 2
table was constructed. Discrepancies were resolved by
discussion between the two reviewers (LG and GC).
Authors were contacted to provide further information
when there was insufficient detail in an article to con-
struct a 2 × 2 table.
Quality assessment
The methodological quality of the selected studies was
evaluated independently by two reviewers (LG and GC)
using the Quality Assessment of Diagnostic Accuracy
Studies (QUADAS) tool, a validated tool for the quality
assessment of diagnostic accuracy studies [19]. This tool
was modified to ensure appropriateness to the present
study and included twelve questions from the QUADAS
tool with two additional questions extracted from a dif-
ferent review [20]. If no consensus was achieved, studies
were evaluated by a third independent reviewer (TF).
Data synthesis and analysis
Summary estimates across different reference standards
We used the bivariate random effects model to estimate
summary estimates of sensitivity and specificity and
their corresponding 95% confidence intervals. This
approach was used as it preserves the two-dimensional
nature of the original data and takes into account both
study size and heterogeneity beyond chance between
studies [21]. In addition, the bivariate model estimates
and incorporates the negative correlation which may
arise between the sensitivity and specificity of a given
sign or symptom as a result of differences in reference
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standards used in different studies. These alternative
thresholds are important when attempting to under-
stand the diagnostic accuracy of symptoms and signs
predicting uncomplicated UTI as studies have used dif-
ferent thresholds ranging from ≥ 102 CFU/ml, ≥ 103
CFU/ml and ≥ 105 CFU/ml. However, pooled estimates
cannot be calculated using the bivariate model with less
than 4 studies.
We plotted the individual and summary estimates of
sensitivity and specificity for each symptom and sign at
the different threshold levels in a receiver operating
characteristic graph, plotting a symptom’s sensitivity
(true positive) on the y axis against 1-specificity (false
negative) on the x axis. We also plotted the 95% confi-
dence region and 95% prediction region around the
pooled estimates to illustrate the precision with which
the pooled values were estimated (confidence ellipse
around the mean value) and to illustrate the amount of
between study variation (prediction ellipse). We assessed
heterogeneity visually using the summary ROC plots
and statistically by using the variance of logit trans-
formed sensitivity and specificity, with smaller values
indicating less heterogeneity among studies.
Bayesian analysis and near patient testing (dipstick)
To examine the influence of threshold effects when con-
sidering alternative reference standards we conducted
subgroup analysis across the three different thresholds:
≥ 102 CFU/ml, ≥ 103 CFU/ml and ≥ 105 CFU/ml. Using
Bayes theorem the post-test odds of a UTI were esti-
mated by multiplying the pretest odds by the likelihood
ratio, where pre-test odds is calculated by dividing the
pre-test probability by (1-pre-test probability) and the
post-test probability equals post-test odds divided by (1 +
post-test odds) [22]. Finally, the diagnostic accuracy of
individual symptoms and signs combined with dipstick
test results for nitrites, leucocyte-esterase and combined
nitrites and leucocyte-esterase, was determined using
data synthesised in a previous high quality systematic
review regarding the diagnostic accuracy of dipstick uri-
nalysis [23].
We used Stata version 10.1(StataCorp, College Station,
Tx, USA), particularly the metandi commands, for all
statistical analyses
Results
Search Strategy
Two researchers (LG, GC) screened all potential articles
and agreed that the full text of 51 articles should be
examined. Nineteen relevant studies were identified by
our search strategy [4,6-10,24-36]. Five additional stu-
dies [37-41] were found by citation searching and two
studies by Google Scholar [42,43]. Ten of the 26 studies
reported all required data [8-10,25,37-42]. The authors
of the remaining papers were contacted for additional
data. Ten authors responded [4,6,7,24,26-28,32,35,43,44]
and six studies were subsequently included
[4,6,7,24,26,43]. The flow diagram of our search strategy
is presented in Figure 1.
Characteristics of included studies
The sixteen studies included 3,711 patients and were
carried out in a primary care setting. One study was
based in the USA [39], two in Canada [4,6], one in New
Zealand [38], eight in the UK [8,9,24,25,37,40,41,43] and
four in other European countries [7,10,26,42]. The mean
weighted prior probability is 65.1 using a reference test
of ≥ 102 CFU/ml. The mean weighted prior probability
using a reference test of ≥ 103 CFU/ml and ≥ 105 CFU/
ml is 55.4% and 44.8% respectively. Summary character-
istics of each included study are presented in Table 1.
Quality assessment
The summary diagram of the quality assessment is
shown in Figure 2. The overall quality of the included
studies ranges from moderate to good. It is important to
note that several studies were conducted before the
introduction of standards for reporting diagnostic accu-
racy studies [37-41]. Spectrum bias is identified as a
potential source of bias across certain studies, with stu-
dies including both complicated and uncomplicated
patients [7,38] or failing to clearly report whether the
study was focusing on complicated or uncomplicated
UTI [26,40]. Partial verification bias is also noted in two
studies whereby only a selected sample of patients’
symptoms are verified by the reference test [24,41].
Furthermore, the presence of un-interpretable test
results and blinding of symptoms and signs and refer-
ence test results are poorly reported.
Diagnostic test accuracy of symptoms and signs
Summary estimates across different reference standard
thresholds
Sixteen studies examined the accuracy of ten different
symptoms and signs of UTI. The pooled sensitivities,
specificities and the respective variance of the logit-
transformed sensitivity and specificity, for individual
symptoms and signs at each of the three reference stan-
dard threshold levels are presented in Tables 2, 3 and 4
respectively. Furthermore, the summary estimates of
positive and negative likelihood ratio’s for individual
symptoms and signs at each of the three threshold levels
are presented in Table 5. Six symptoms are identified as
having useful diagnostic value at a reference standard
threshold of ≥ 102 CFU/ml, as their 95% confidence
interval values do not cross the line of no effect. Pre-
sence of dysuria, frequency, hematuria, nocturia and
urgency are found to increase the probability of UTI.
Presence of vaginal discharge decreases the probability
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of UTI. Presence of hematuria in urine has the highest
diagnostic utility (LR+ 1.72), with a specificity of 0.85
and a sensitivity of 0.25, thus hematuria when present is
more useful in ‘ruling in’ UTI. In contrast, all other sig-
nificant symptoms are identified as being more useful in
‘ruling out’. A similar pattern of results emerge using a
higher reference standard threshold ≥ 103 CFU/ml. Con-
sistent with lower threshold effects dysuria, frequency
and urgency remain significant symptoms for ruling out
a urinary tract infection at ≥ 105 CFU/ml.
The individual and summary estimates of sensitivity
and specificity, the 95% confidence region and 95% pre-
diction region for each symptom and sign at each of the
threshold levels are presented in a receiver operating
characteristic graph in figures 3, 4 and 5. The 95% con-
fidence region remains large for several symptoms and
signs across the different diagnostic thresholds, with the
exception of dysuria, frequency and hematuria. This
indicates greater precision of the pooled estimates for
dysuria, frequency and hematuria. The 95% prediction
Figure 1 Flow diagram of studies in the review.
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Table 1 Summary of included studies
Study Inclusion criteria No. of
patients
Mean age, y
(range)
Incidence
of UTI%
Reference
Test
Setting and country
McIsaac 2002 Women ≥ 16 y presenting with
symptoms of UTI
N =231 M = 43.9
(20-92)
53.2% ≥ 102 CFU/ml 4 urban academic family medicine
clinics in Canada
McIsaac 2007 Women ≥ 16 y presenting with
symptoms of UTI
N = 331 M = 45.2
(16-99)
62.8% ≥ 102 CFU/ml 225 Physicians from every
province in Canada
Lawson 1973 Women presenting with
symptoms of UTI
N = 343 M =? (15-55) 34.4% ≥ 102 CFU/ml 2 general practices in the UK
≥ 103 CFU/ml
≥ 105 CFU/ml
Nazareth &
King 1993
Women presenting with
symptoms of lower UTI
N = 54 M = 29
(16-45)
27.8% ≥ 102 CFU/ml 2 general practices in the UK
≥ 103 CFU/ml
Little 2006 Women with suspected UTI N= 408 M = ? (17-70) 62.3% ≥ 102 CFU/ml 67 general practices in the UK
≥ 103 CFU/ml
Little 2009 Women with suspected UTI N = 431 M = ? (17-70) 66.6% ≥ 102 CFU/ml 62 general practices in the UK
≥ 103 CFU/ml
Dobbs &
Fleming 1987
Women presenting with
symptoms of UTI
N = 238 M = ? (?) 35.7% ≥ 102 CFU/ml 3 general practices in the UK
≥ 103 CFU/ml
Mond 1965 Women with symptoms of UTI N = 83 M =? (?) 45.8% ≥ 102 CFU/ml 1 general practice in the UK
≥ 103 CFU/ml
≥ 105 CFU/ml
Medina-
Bombardo 2003
Women presenting with
symptoms of UTI
N = 343 M = 44
(15-90)
48.4% ≥ 102 CFU/ml 18 primary health care centres in
Spain
≥ 103 CFU/ml
≥ 105 CFU/ml
Dans & Klaus
1975
Women complaining of dysuria N = 84 M = 26
(19-60)
46.4% ≥ 102 CFU/ml Adult walk-in clinic in the US
≥ 103 CFU/ml
Gallagher 1965 Women with symptoms of UTI N = 130 M=? (?) 59.2% ≥ 102 CFU/ml Urban general practices in New
Zealand
≥ 103 CFU/ml
Fahey 2003 Women presenting with
symptoms of UTI
N = 85 M= (?) 35.7% ≥ 102 CFU/ml 8 general practices in the UK
≥ 103 CFU/ml
≥ 105 CFU/ml
Baerheim 2003 Women with acute dysuria/
frequency
N = 252 M = 46 for UTI
+
63.3% ≥ 102 CFU/ml 8 general practices in Norway
≥ 103 CFU/ml
M = 42 for
UTI-(18-87)
≥ 105 CFU/ml
Osterberg 1996 Women with symptoms of
dysuria/frequency
N= 214 M = 24
(15-35)
51.4% ≥ 102 CFU/ml 5 primary health care centres in
Sweden
≥ 103 CFU/ml
Hummers-
Pradier 2005
Women with symptoms of UTI N = 227 M = 53 (?) 79.3% ≥ 102 CFU/ml 36 general practices in Germany
68.7% ≥ 103 CFU/ml
49.3% ≥ 105 CFU/ml
O’Brien 2007 Women with clinically suspected
uncomplicated UTI
N = 111 M = 54 (?) 32.4% ≥ 102 CFU/ml 9 general practices in the UK
≥ 103 CFU/ml
≥ 105 CFU/ml
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region (amount of variation between studies) is also
wide for most symptoms and signs across the different
diagnostic thresholds, as reflected in the large values for
the variance of logit-transformed sensitivity and specifi-
city, with the exception of hematuria.
Bayesian analysis and near patient testing (dipstick)
Using Bayes theorem the post-test probability across the
three threshold levels are presented in table 6. Most
notable, presence of hematuria increases the pre-test
probability from 65.1% to 75.8% (95% CI 70.9 - 80.1)
Figure 2 Quality assessment. Included questions from the Quadas Tool: [19] 1. Was the spectrum of patient’s representative of the patients
who will receive the test in practice? (Q1). 2. Were selection criteria clearly described? (Q2). 3. Is the reference standard likely to correctly classify
the target condition? (Q3). 4. Is the time period between reference standard and index test short enough to be reasonably sure that the target
condition did not change between the two tests? (Q4). 5. Did the whole sample or a random selection of the sample receive verification using a
reference standard of diagnosis? (Q5). 6. Did patients receive the same reference standard regardless of their symptoms and signs? (Q6). 7. Were
all signs and symptoms clearly defined? (Q7). 8. Was the execution of the urine culture described in sufficient detail to permit replication? (Q8).
9. Were signs and symptoms interpreted without knowledge of the results of urine culture? (Q9). 10. Were the results of the urine culture
interpreted without knowledge of the symptoms and signs? (Q10). 11. Were uninterpretable/intermediate test results reported? (Q11). 12. Were
withdrawals from the study explained? (Q12). Additional question: [20]. 13. Were the patients selected consecutively? (Q13). 14. Were statistical
tests for main outcome adequate? (Q14).
Table 2 Summary estimates of sensitivity and specificity using a bivariate random effects model (102)
SYMPTOM No. of
studies
No. of
Patient
Sensitivity (95% CI) Variance Logit
(sensitivity)
Specificity (95% CI) Variance Logit
(specificity)
Dysuriaa 14 3407 0.80 (0.74-0.86) 0.40 0.38 (0.31-0.46) 0.33
Frequencyb 13 2807 0.88 (0.83-0.92) 0.41 0.20 (0.14-0.28) 0.58
Back painc 4 635 0.38 (0.26-0.52) 0.22 0.57 (0.40-0.73) 0.43
Feverd 7 1250 0.10 (0.04-0.21) 1.19 0.92 (0.83-0.97) 1.07
Flank paine 6 1340 0.26 (0.19-0.35) 0.21 0.69 (0.64-0.74) 0.04
Hematuria 7 1078 0.25 (0.21-0.29) 0.01 0.85 (0.81-0.89) 0.05
Lower
abdominal painf
7 1470 0.50 (0.34-0.66) 0.75 0.50 (0.34-0.66) 0.72
Nocturia 6 1720 0.59 (0.50-0.68) 0.17 0.55 (0.49-0.61) 0.06
Urgencyg 9 2298 0.67 (0.52-0.80) 0.95 0.45 (0.31-0.60) 0.79
Vaginal
discharge
6 1261 0.15 (0.08-0.26) 0.65 0.77 (0.62-0.88) 0.75
a Three studies reported dysuria as painful voiding (McIsaac 2002, McIsaac 2007, Medina-Bombardo 2003).
b One study reported frequency as frequency/dysuria (Dans&Klaus).
c One study reported back pain as ‘back or groin pain’ (O’Brien).
d One study reported fever as pyrexia (Lawson 1973).
e One study reported flank pain as loin pain (Lawson 1973).
f Different definitions were used: ‘Suprapubic pain’ (Hummer-Pradier 2005), Suprapubic pressure’ (Baerheim), ‘abdominal pain’ (Fahey 2003).
g One study reported urgency as urgency/frequency (Hummers-Pradier 2005).
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using ≥ 102 CFU/ml and to 67.4% (95% CI 60.6 - 73.6)
using ≥ 103 CFU/ml. Presence of vaginal discharge
decreases the pre-test probability from 65.1% to 54.1%
(95% CI 48.3 - 59.9). The probability of a UTI increases
to 93.3% (≥ 102 CFU/ml) and 90.1% (≥ 103 CFU/ml)
when the presence of hematuria is combined with a
positive dipstick test for nitrites (table 7). Combining
the presence of hematuria with a positive dipstick test
for leucocyte-esterase increases the probability to 81%
and 73.8% respectively (table 8). The post-test probabil-
ity of UTI when the presence of dysuria, frequency, noc-
turia, hematuria and urgency is combined with either
positive dipstick test for leucocyte-esterase or a combi-
nation of nitrites and leucocyte-esterase is also lower
relative to positive symptoms combined with nitrites
alone (table 8, 9). In contrast, the presence of vaginal
discharge combined with a negative dipstick test result
for nitrites reduces the probability of UTI to 38.4%
(table 7). The presence of vaginal discharge combined
with a negative result for combined nitrites and
leucocyte-esterase dipstick test reduces the post-test
probability further to 15% (table 9).
Discussion
Principal findings
Individual symptoms and signs suggestive of a UTI have
modest diagnostic discriminative value when assessed
against three reference standard thresholds for UTI.
Dysuria, frequency and urgency have a higher sensitivity
than specificity and are more useful in ruling out a UTI
diagnosis when absent across all three reference stan-
dard thresholds ≥ 102 CFU/ml, ≥ 103 CFU/ml and ≥ 105
CFU/ml. In contrast, hematuria has a higher specificity
than sensitivity and is more useful in ruling in a diagno-
sis of UTI when present across the reference standard
thresholds ≥ 102 CFU/ml and ≥ 103 CFU/ml. Combining
positive dipstick test results, particularly tests for
nitrites, with symptoms increases post-test probability of
a UTI. In particular, presence of hematuria combined
with a positive dipstick test result for nitrites increases
Table 3 Summary estimates of sensitivity and specificity, using a bivariate random effects model (103)
SYMPTOM No. of
studies
No. of
Patient
Sensitivity (95% CI) Variance Logit
(sensitivity)
Specificity (95% CI) Variance Logit
(specificity)
Dysuriaa 12 2845 0.79 (0.72-0.85) 0.39 0.39 (0.31-0.49) 0.40
Frequencyb 11 2246 0.88 (0.82-0.92) 0.43 0.21 (0.14-0.31) 0.64
Back painc 4 635 0.38 (0.26-0.52) 0.22 0.57 (0.40-0.73) 0.43
Feverd 6 926 0.12 (0.05-0.26) 1.15 0.91 (0.80-0.97) 1.16
Flank paine 4 783 0.29 (0.18-0.43) 0.31 0.65 (0.59-0.70) 0.01
Hematuria 6 854 0.22 (0.18-0.27) 0.02 0.87 (0.81-0.91) 0.11
Lower
abdominal painf
5 914 0.44 (0.26-0.64) 0.78 0.58 (0.37-0.77) 0.86
Nocturia 5 1492 0.59 (0.48-0.70) 0.22 0.57 (0.51-0.62) 0.04
Urgencyg 7 1739 0.62 (0.46-0.76) 0.72 0.51 (0.35-0.68) 0.78
a One study reported dysuria as painful voiding (Medina-Bombardo 2003)
b Two studies reported frequency/dysuria (Dans&Klaus, Wigton: training and validation set)
c One study reported back pain as ‘back or groin pain’ (O’Brien)
d One study reported fever as pyrexia (Lawson 1973)
e One study reported flank pain as loin pain (Lawson 1973)
f Different definitions were used: ‘Suprapubic pain’ (Hummer-Pradier 2005), Suprapubic pressure’ (Baerheim), ‘abdominal pain’ (Fahey 2003)
g One study reported urgency as urgency/frequency (Hummers-Pradier 2005)
Table 4 Summary estimates of sensitivity and specificity using a bivariate random effects model (105)
SYMPTOM No. of
studies
No. of
Patient
Sensitivity (95% CI) Variance Logit
(sensitivity)
Specificity (95% CI) Variance Logit
(specificity)
Dysuriaa 7 1584 0.78 (0.68-0.86) 0.42 0.36 (0.26-0.48) 0.37
Frequency 6 1333 0.90 (0.85-0.94) 0.22 0.17 (0.11-026) 0.38
Feverd 4 742 0.10 (0.04-0.23) 0.82 0.89 (0.75-0.95) 0.79
Lower
abdominal painf
4 784 0.40 (0.21-0.62) 0.74 0.64 (0.41-0.82) 0.83
Urgencyg 4 1039 0.75 (0.69-0.80) 0.05 0.36 (0.27-0.46) 0.14
a One study reported dysuria as painful voiding (Medina-Bombardo 2003).
d One study reported fever as pyrexica (Lawson 1973.
f Different definitions were used: ‘Suprapubic pain’ (Hummer-Pradier 2005), Suprapubic pressure’ (Baerheim), ‘abdominal pain’ (Fahey 2003).
g One study reported urgency as urgency/frequency (Hummers-Pradier 2005).
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the post-test probability from 75.8% to 93.3% at ≥ 102
CFU/ml and from 67.4% to 90.1% at ≥ 103 CFU/ml.
Similarly, presence of dysuria combined with a positive
dipstick test result for nitrites increases post- test prob-
ability from between 51.1% to 82.2% at ≥ 105 CFU/ml.
Context of previous studies
The findings of this systematic review are consistent with
a previous systematic review which concluded that no
sign or symptom on its own is powerful enough to ‘rule
in’ or ‘rule out’ the diagnosis of UTI [14]. However, the
relative diagnostic importance of individual symptoms
and signs varies between this review and the previous
systematic review [14]. The previous systematic review
found that presence of dysuria, frequency, hematuria,
back pain and costovertebral angle tenderness increase
the probability of UTI using a diagnostic threshold ran-
ging from between ≥ 102 CFU/ml and ≥ 105 CFU/ml,
also history of vaginal discharge, history of vaginal irrita-
tion and vaginal discharge on examination decrease the
probability of a UTI. In this systematic review we found
that dysuria and frequency increase the probability of
UTI across different reference standard thresholds ≥ 102
CFU/ml, ≥ 103 CFU/ml and ≥ 105 CFU/ml. Hematuria is
Table 5 Summary estimates of positive and negative likelihood ratio’s, using a bivariate random effects model (102,
103, 105)
≥ 102 CFU/ml ≥ 103 CFU/ml ≥ 105 CFU/ml
SYMPTOM +LR (95% CI) -LR (95% CI) +LR (95% CI) -LR (95% CI) +LR (95% CI) -LR (95% CI)
Dysuria 1.30 (1.20-1.41) 0.51 (0.43-0.61) 1.31 (1.18-1.45) 0.53 (0.43-0.64) 1.22 (1.11-1.34) 0.61 (0.50-0.74)
Frequency 1.10 (1.04-1.16) 0.60 (0.49-0.74) 1.12 (1.03-1.19) 0.59 (0.46-0.76) 1.09 (1.02-1.16) 0.58 (0.42-0.79)
Back pain 0.90 (0.71-1.14) 1.07 (0.90-1.28) 0.90 (0.71-1.14) 1.07 (0.90-1.28)
Fever 1.28 (0.64-2.58) 0.98 (0.91-1.05) 1.39 (0.63-3.07) 0.96 (0.88-1.06) 0.90 (0.45-1.80) 1.01 (0.93-1.10
Flank pain 0.85 (0.67-1.08) 1.07 (0.98-1.17) 0.83 (0.56-1.24) 1.09 (0.92-1.29)
Hematuria 1.72 (1.30-2.27) 0.88 (0.83-0.93) 1.68 (1.06-2.66) 0.89 (0.82-0.98)
Lower abdominal pain 1.01 (0.89-1.15) 0.99 (0.87-1.13) 1.06 (0.88-1.29) 0.96 (0.83-1.10) 1.10 (0.87-1.38) 0.94 (0.82-1.08)
Nocturia 1.30 (1.08-1.56) 0.75 (0.60-0.94) 1.37 (1.13-1.65) 0.72 (0.56-0.93)
Urgency 1.22 (1.11-1.34) 0.73 (0.62-0.86) 1.28 (1.11-1.47) 0.74 (0.64-0.85) 1.17 (1.04-1.31) 0.70 (0.57-0.86)
Vaginal discharge 0.65 (0.51-0.83) 1.10 (1.01-1.20)
Figure 3 Receiver operating characteristic graphs with 95%-confidence region and 95%- prediction region for each sign and symptom (102).
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also significant in the present study using a diagnostic
threshold of ≥ 102 CFU/ml and ≥ 103 CFU/ml. However,
in contrast to the previous systematic review back pain is
not significantly associated with UTI across the different
reference standard thresholds. Vaginal discharge is iden-
tified as an important symptom for decreasing the prob-
ability of UTI in the present study.
Such differences may be an artefact of different meth-
odological approaches taken. Firstly, the previous sys-
tematic review pooled all studies irrespective of the
reference standard threshold used, whereas the present
study sought to determine the importance of individual
symptoms and signs at different reference standard
thresholds. In addition, our inclusion criteria was more
conservative, excluding studies which involved self-diag-
nosis, case-control study designs and different health-
care settings (i.e. not primary care settings) where the
prevalence of symptoms may differ and increase the
chance of spectrum bias.
Strengths and limitations of this study
The systematic search, the conservative inclusion criteria,
the inclusion of additional data from authors, and the qual-
ity assessment of the included studies can be seen as
strengths of this study. In addition, given the lack of con-
sensus regarding reference standard thresholds for UTI, the
current study is the first study to determine the diagnostic
accuracy of symptoms and signs across the three thresholds
≥ 102 CFU/ml, ≥ 103 CFU/ml and ≥ 105 CFU/ml. Lastly,
this study highlights the additional importance of using
dipstick test, particularly tests for nitrites, as an additional
diagnostic tool when ruling in a UTI diagnosis based on
particular symptomatology.
We acknowledge that this review has limitations. Varia-
bility of diagnostic accuracy estimates across studies is
high. This may be due to the fact that we did not restrict
the age of women included in the meta-analysis. It is
known that the prevalence of UTI differs across age
groups, peaking at 15-24 years and greater than 65 years
[45]. In addition definitions used to describe individual
symptoms and signs vary across studies. For example,
‘lower abdominal pain’ has been defined as ‘suprapubic
pain’ [4,6,7], ‘suprapubic pressure’ [42] or ‘abdominal pain’
[24]. Furthermore, as the bivariate random effects model is
used symptoms and signs are analysed, when at least 4
studies are included. Therefore few symptoms and signs
are excluded from our meta-analysis particularly at the
higher reference standard threshold of ≥ 105 CFU/ml.
Finally, while the probability of UTI increases when the
presence of certain symptoms are combined with positive
dipstick test results, it is important to acknowledge that
the predictive value of the dipstick test result, was taken
from a meta-analysis which included men and pregnant
women [23].
Implications for practice
Individual symptoms and signs will modestly increase
the post-test probability and cannot accurately ‘rule in’
Figure 4 Receiver operating characteristic graphs with 95%-confidence region and 95%- prediction region for each sign and symptom (103).
Giesen et al. BMC Family Practice 2010, 11:78
http://www.biomedcentral.com/1471-2296/11/78
Page 9 of 14
or ‘rule out’ the diagnosis of a UTI. Subgroup analysis
shows improved diagnostic accuracy using lower refer-
ence standards of ≥ 102 CFU/ml and of ≥ 103 CFU/ml.
In addition, combining nitrite dipstick test results with
clinical symptoms and signs is useful for ruling in a UTI
diagnosis and deciding on the optimal patient manage-
ment strategy. More recently, formal clinical prediction
rules for UTI that incorporate the independent effects
of symptoms and signs into a “risk score” have been
proposed as an alternative management strategy when
considering antibiotic treatment [8]. This approach
appears to be equivalent to alternative management
strategies for UTI in women including empirical
immediate antibiotics, empirical delayed antibiotics, or
use of near-patient testing with a dipstick in terms of
duration or severity of symptoms. However, in terms of
antibiotic usage, use of a dipstick results in fewer anti-
biotics being prescribed when compared to immediate
empirical antibiotics or use of a UTI “risk score” [46].
Future studies
The current approach of evaluating symptoms and signs
as a diagnostic test is in general two-dimensional, and
ignores symptom severity [8,9,28] In the future, focusing
on severity of symptoms may provide more valuable
diagnostic information.
Conclusions
Individual symptoms and signs, independent of refer-
ence standard threshold have a modest ability to ‘rule
in’ or ‘rule out’ the diagnosis of UTI. Use of a dipstick
test enhances diagnostic utility and reduces the chance
Figure 5 Receiver operating characteristic graphs with 95%-confidence region and 95%-prediction region for each sign and symptom (105).
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Table 6 Post-test probability of significant symptoms across three different reference standards 102, 103 and 105 CFU/
ml
Symptom Reference standard* +LR (95%CI) Post-test probability
(95%CI) (%)
Dysuria 102 CFU/ml 1.30 (1.20-1.41) 71.0 (70.0-71.0)
103 CFU/ml 1.31 (1.18-1.45) 62.3 (61.0-63.6)
105 CFU/ml 1.22 (1.11-1.34) 51.1 (49.5-52.8)
Frequency 102 CFU/ml 1.10 (1.04-1.16) 67.8 (67.0-68.5)
103 CFU/ml 1.12 (1.03-1.19) 58.6 (57.5-59.5)
105 CFU/ml 1.09 (1.02-1.16) 47.8 (46.7-49.0)
Hematuria 102 CFU/ml 1.72 (1.30-2.27) 75.8 (70.9-80.1)
103 CFU/ml 1.68 (1.06-2.66) 67.4 (60.6-73.6)
Nocturia 102 CFU/ml 1.30 (1.08-1.56) 69.4 (67.3-71.3)
103 CFU/ml 1.37 (1.13-1.65) 60.8 (58.4-63.3)
Urgency 102 CFU/ml 1.22 (1.11-1.34) 69.8 (68.5-71.1)
103 CFU/ml 1.28 (1.11-1.47) 61.7 (59.9-63.6)
105 CFU/ml 1.17 (1.04-1.34) 49.1 (47.1-51.1)
Vaginal discharge 102 CFU/ml 0.65(0.51-0.83) 54.1 (48.3 - 59.9)
* Pretest probability is 65.1% at ≥ 102 CFU/ml; 55.4% at ≥ 103 CFU/ml and 44.8% at ≥ 105 CFU/ml.
Table 7 Post-test probability of significant symptoms with a positive (LR 4.42) or negative dipstick (LR 0.53) test for
nitrites [23]
Symptom Reference standard Pre-test probability
(95%CI) (%)
Post-test probability
(95% CI) (LR+)
Post-test probability
(95% CI) (LR-)
Dysuria 102 CFU/ml 71.0 (70.0-71.0) 91.5 (91.2-92.0) 56.5 (55.3-56.5)
103 CFU/ml 62.3 (61.0-63.6) 88.0 (87.4-88.5) 46.7 (45.3-48.1)
105 CFU/ml 51.1 (49.5-52.8) 82.2 (81.2-83.2) 35.6 (34.2-37.2)
Frequency 102 CFU/ml 67.8 (67.0-68.5) 90.3 (90.0-91.0) 52.7 (51.8-53.5)
103 CFU/ml 58.6 (57.5-59.5) 86.2 (85.7-87.0) 42.9 (41.8-43.8)
105 CFU/ml 47.8 (46.7-49.0) 80.2 (79.5-81.0) 32.7 (31.7-33.7)
Hematuria 102 CFU/ml 75.8 (70.9-80.1) 93.3 (91.5-95.0) 62.4 (56.4-68.1)
103 CFU/ml 67.4 (60.6-73.6) 90.1 (87.2-92.5) 52.3 (44.9-59.6)
Nocturia 102 CFU/ml 69.4 (67.3-71.3) 91.0 (90.1-92.0) 54.6 (52.1-56.8)
103 CFU/ml 60.8 (58.4-63.3) 87.3 (86.1-88.4) 45.1 (42.7-47.8)
Urgency 102 CFU/ml 69.8 (68.5-71.1) 91.0 (90.6-91.6) 55.1 (53.5-56.6)
103 CFU/ml 61.7 (59.9-63.6) 87.7 (86.8-88.5) 46.1 (44.2-48.1)
105 CFU/ml 49.1 (47.1-51.1) 81.0 (79.7-82.2) 33.8 (32.1-35.6)
Vaginal discharge 102 CFU/ml 54.1 (48.3 - 59.9) 84.0 (80.5-86.8) 38.4 (33.1-44.2)
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Table 8 Post-test probability of significant symptoms with a positive (LR 1.36) or negative dipstick (LR 0.36) test for
leucocyte-esterase [23]
Symptom Reference standard Pre-test probability
(95%CI) (%)
Post-test probability
(95%CI) (LR+)
Post-test probability
(95% CI) (LR-)
Dysuria 102 CFU/ml 71.0 (70.0-71.0) 76.9 (76.0-76.9) 46.8 (45.7-46.8)
103 CFU/ml 62.3 (61.0-63.6) 69.2 (68.0-70.4) 37.3 (36.0-38.6)
105 CFU/ml 51.1 (49.5-52.8) 58.7 (57.1-60.3) 27.3 (26.1-28.7)
Frequency 102 CFU/ml 67.8 (67.0-68.5) 74.1 (73.4-74.7) 43.1 (42.2-43.9)
103 CFU/ml 58.6 (57.5-59.5) 65.8 (64.8-66.6) 33.8 (32.8-34.6)
105 CFU/ml 47.8 (46.7-49.0) 55.5 (54.4-56.6) 24.8 (24.0-25.7
Hematuria 102 CFU/ml 75.8 (70.9-80.1) 81.0 (76.8-84.6) 53.0 (46.7-59.2)
103 CFU/ml 67.4 (60.6-73.6) 73.8 (67.7-79.1) 42.7 (35.6-50.1)
Nocturia 102 CFU/ml 69.4 (67.3-71.3) 75.5 (73.7-77.2) 44.9 (42.6-47.2)
103 CFU/ml 60.8 (58.4-63.3) 67.8 (65.6-70.1) 35.8 (33.6-38.3)
Urgency 102 CFU/ml 69.8 (68.5-71.1) 75.9 (74.7-77.0) 45.4 (43.9-47.0)
103 CFU/ml 61.7 (59.9-63.6) 68.7 (67.0-70.4) 36.7 (35.0-38.6)
105 CFU/ml 49.1 (47.1-51.1) 56.7 (55.0-58.7) 25.8 (24.3-27.3)
Vaginal discharge 102 CFU/ml 54.1 (48.3 - 59.9) 61.6 (56.0-67.0) 29.8 (25.2-35.0)
Table 9 Post-test probability of significant symptoms with a positive (LR 2.57) or negative dipstick (LR 0.15) test for
nitrites and leucocyte-esterase combined [23]
Symptom Reference standard Pre-test probability
(95%CI) (%)
Post-test probability
(95%CI) (LR+)
Post-test probability
(95%CI) (LR-)
Dysuria 102 CFU/ml 71.0 (70.0-71.0) 86.3(85.7-86.3) 26.9 (25.9-26.9)
103 CFU/ml 62.3 (61.0-63.6) 80.9(80.1-81.8) 19.9 (19.0-20.8)
105 CFU/ml 51.1 (49.5-52.8) 72.9(71.6-74.2) 13.6 (12.8-14.3)
Frequency 102 CFU/ml 67.8 (67.0-68.5) 84.4(83.9-84.8) 24.0 (23.3-24.6)
103 CFU/ml 58.6 (57.5-59.5) 78.4(77.7-79.1) 17.5 (16.9-18.1)
105 CFU/ml 47.8 (46.7-49.0) 70.2(69.2-71.1) 12.1 (11.6-12.6)
Hematuria 102 CFU/ml 75.8 (70.9-80.1) 89.0(86.2-91.2) 32.0 (26.8-37.6)
103 CFU/ml 67.4 (60.6-73.6) 84.2(79.8-87.8) 23.7 (18.7-29.5)
Nocturia 102 CFU/ml 69.4 (67.3-71.3) 85.4(84.1-86.5) 25.4 (23.6-27.1)
103 CFU/ml 60.8 (58.4-63.3) 80.0(78.3-81.6) 18.9 (17.4-20.6)
Urgency 102 CFU/ml 69.8 (68.5-71.1) 85.6(84.8-86.3) 25.7 (24.6-27.0)
103 CFU/ml 61.7 (59.9-63.6) 80.5(79.3-81.8) 19.5 (18.3-20.8)
105 CFU/ml 49.1 (47.1-51.1) 71.3(69.6-72.9) 12.6 (11.8-13.6)
Vaginal discharge 102 CFU/ml 54.1 (48.3 - 59.9) 75.2 (71.0-79.3) 15.0(12.3-18.3)
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of prescribing unnecessary antibiotics. Future studies
should focus on the refinement of diagnosis utilising
information on severity and duration of symptoms,
alone, in combination and alongside dipstick testing.
Additional material
Additional file 1: PRISMA checklist. Guidelines for the reporting on
systematic reviews and meta-analyses
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